[67Ga]citrate scintiscanning in active inflammatory bowel disease

Area of Science:

• Nuclear Medicine
• Gastroenterology
• Diagnostic Imaging

Background:

• Inflammatory bowel disease (IBD) diagnosis and monitoring present challenges.
• Differentiating ulcerative colitis (UC) and Crohn's disease (CD) is crucial for treatment.
• The role of Gallium-67 citrate (GA) abdominal scanning in active IBD requires definition.

Purpose of the Study:

• To evaluate the efficacy of [67Ga]citrate (GA) abdominal scintigraphy in hospitalized patients with active IBD.
• To determine if GA scans can differentiate between UC and CD.
• To assess the utility of GA scans in disease monitoring and distinguishing CD from intraabdominal abscess.

Main Methods:

• Prospective study of 25 hospitalized patients with active IBD (9 UC, 7 CD) and 9 controls.
• Abdominal scintigraphy using [67Ga]citrate.
• Delayed imaging (3-5 days) compared to early imaging (6 hours).
• Measurement of tissue/plasma radioactivity ratios in a subset of patients.

Main Results:

• All nine UC patients showed positive GA scans; only one of seven CD patients had a positive scan.
• No false positive scans were observed.
• Delayed scans (3-5 days) demonstrated higher accuracy than 6-hour scans alone.
• UC scans showed persistent colonic radioactivity (3-5 days); active CD scans were typically negative.
• Tissue/plasma radioactivity ratios were elevated in UC and normal/decreased in CD, correlating with imaging findings.

Conclusions:

• [67Ga]citrate abdominal scintigraphy is a valuable tool for diagnosing active ulcerative colitis.
• Delayed GA scans aid in differentiating UC from active Crohn's disease.
• The imaging technique assists in disease course monitoring and distinguishing CD from intraabdominal abscesses.